Andrew Gu
Director · Cellectar Biosciences, Inc.
Individual
- 2026
- Jul 9, 2026
- 1
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Gu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James V. Caruso - $25K in CLRB purchases and sales in the last 12 months
- Jarrod Longcor - $25K in CLRB purchases and sales in the last 12 months
- John Neis - $732 in CLRB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Gu?
Andrew Gu is a corporate insider, tracked as Director of Cellectar Biosciences, Inc. (CLRB). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Andrew Gu last file a Form 4?
The only primary Form 4 on record is dated 9 July 2026.